|
|
||||||||
From the Departments of Neurology (Drs. Sharma and Gutmann, M. Lyman) and Pathology and Immunology (Drs. Watson and Perry), Washington University School of Medicine, St. Louis, MO, Department of Pathology (Dr. Aldape), University of Texas M.D. Anderson Cancer Center, Houston, and Institute of Biochemistry (Dr. Deák), Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungary.
Address correspondence and reprint requests to Dr Gutmann, Department of Neurology, Washington University School of Medicine, Box 8111, 660 S. Euclid Ave., St. Louis, MO 63110; e-mail: gutmannd{at}neuro.wustl.edu
Using whole genome expression microarray technology to discover clinically relevant biomarkers for pilocytic astrocytoma (PA), the authors identified matrilin-2 as a unique mRNA overexpressed in PA. Matrilin-2 protein expression was similarly elevated in the majority of sporadic PA, but in only one neurofibromatosis 1-associated PA with an unusually aggressive clinical phenotype. These results suggest that matrilin-2 may be a specific and clinically useful biomarker for discriminating between indolent and clinically aggressive PA.
This article was previously published in electronic format on November 9, 2005, as an Expedited E-Pub at www.neurology.org.
Supported by Schnuck Markets, Inc. (D.H.G.), and OM-255/02 (F.D.).
Disclosure: The authors report no conflicts of interest.
Received July 14, 2005. Accepted in final form September 23, 2005.
This article has been cited by other articles:
![]() |
J. Yu, H. Deshmukh, R. J. Gutmann, R. J. Emnett, F. J. Rodriguez, M. A. Watson, R. Nagarajan, and D. H. Gutmann Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma Neurology, November 10, 2009; 73(19): 1526 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tchoghandjian, C. Fernandez, C. Colin, I. El Ayachi, B. Voutsinos-Porche, F. Fina, D. Scavarda, M.-D. Piercecchi-Marti, D. Intagliata, L. Ouafik, et al. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature Brain, June 1, 2009; 132(6): 1523 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Houshmandi, E. I. Surace, H. B. Zhang, G. N. Fuller, and D. H. Gutmann Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor Neurology, November 28, 2006; 67(10): 1863 - 1866. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |